KIF13A - N-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-KIF13A - N-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | KIF13A - N-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against KI13A. It was validated on Western BlotTarget Description: This gene encodes a member of the kinesin family of microtubule-based motor proteins that function in the positioning of endosomes. This family member can direct mannose-6-phosphate receptor-containing vesicles from the trans-Golgi network to the plasma membrane, and it is necessary for the steady-state distribution of late endosomes/lysosomes. It is also required for the translocation of FYVE-CENT and TTC19 from the centrosome to the midbody during cytokinesis, and it plays a role in melanosome maturation. Alternative splicing of this gene results in multiple transcript variants. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the N-terminal region of Human KI13A |
| Other Names | [kinesin-like protein KIF13A isoform a; Kinesin-like protein KIF13A; kinesin-like protein KIF13A; kinesin family member 13A; Kinesin-like protein RBKIN] |
| Gene, Accession # | [KIF13A], Gene ID: 63971, NCBI: NP_071396, UniProt: Q9H1H9 |
| Catalog # | MBS3219508 |
| Price | $335 |
| Order / More Info | KIF13A - N-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies